Chinook Therapeutics Funding: $65M Raised, Series A (2019)
Chinook Therapeutics is based in Vancouver, Canada. It has raised $65M in total funding. Latest round: Series A.
Chinook Therapeutics funding overview
Chinook Therapeutics is based in Vancouver, Canada. Chinook Therapeutics has raised $65M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in August 2019. The round record for Chinook Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include Versant Ventures, Apple Tree Partners, Samsara BioCapital. 3 distinct backers are named across the disclosed rounds.
Chinook Therapeutics at a glance
Total raised
$65M
Latest round
Series A
Latest round date
August 2019
Headquarters
Vancouver, Canada
Notable investors
Versant Ventures, Apple Tree Partners, Samsara BioCapital
Frequently asked about Chinook Therapeutics funding
How much has Chinook Therapeutics raised?
Chinook Therapeutics has raised $65M in total disclosed funding across the rounds on record.
Who has invested in Chinook Therapeutics?
Versant Ventures, Apple Tree Partners, Samsara BioCapital are named among the investors backing Chinook Therapeutics.
What was the latest Chinook Therapeutics funding round?
The most recent disclosed round is a Series A, announced in August 2019.
Where is Chinook Therapeutics based?
Chinook Therapeutics is based in Vancouver, Canada.
When did Chinook Therapeutics last raise?
The last disclosed Chinook Therapeutics round closed in August 2019 at Series A.
Chinook Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Vancouver below to benchmark round size and investor mix.
